|Day Low/High||14.00 / 14.05|
|52 Wk Low/High||8.28 / 16.15|
You may want to start taking profits now. Plus, charts of AOL, Intel and more.
Traders might take the jobs report today as an opportunity to focus on economic fundamentals again.
Take a look at charts from Apache and Advanced Fibre to Zimmer and more.
The market recovered after a terror scare in New York, and the indices look ready for another leg up next week.
That's what these charts are indicating. Plus, Nokia, Expedia and more.
Some of the projected savings from big deals such as Pfizer-Pharmacia may come from equipment orders.
Cramer follows up on a Motley Fool's misguided recommendation to short Affymetrix.
A whole array of star stocks crashed last year; here's some rules to decide which ones to toss.
The sector's bulls feel the same disappointment as Amgen, Praecis and Affymetrix.
The news has analysts rethinking rosy assumptions about the short-term health of this group.
Wall Street digests a 0.1% rise in May's retail sales. Kraft is up some 2% as it begins trading.
Analysts are concerned with a lack of visibility, but most see a bright spot in the firm's dominant position.
Due to slow sales, the equipment maker says it will lose far more than the penny a share that's expected.
Task's inner cynic is cringing at this market and crying out for some healthy skepticism.
Sky-high valuation and a revenue warning make it the NYSE's worst quarterly performer.
GMP boasts an ample supply of biotech stars but little in terms of revenue or product. Is this market ready for this deal?
This sector, up huge in recent months, has been prone to excess -- and steep drops -- before.
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.